Sarepta to pay $200M milestone to Arrowhead; Enlivex reports osteoarthritis data

Plus, news about Clearside Biomedical, Pfizer, Astellas, Merck, MindImmune Therapeutics and Poxel:

💵 Sarepta to pay Arrowhead $200M as it continues type 1 myotonic dystrophy study: Sarepta

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registeration number 16808844